Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
In Aliens: Dark Descent, your squad will have to survive onslaughts and hordes of enemies coming at you, all while trying to complete the ongoing main story. This guide will help you understand how ...
Aliens: Dark Descent has a plethora of perks players can assign to their Marines. These perks are more than numerous and the sheer size of options can make it seem a bit too daunting when it comes to ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results